25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

American Oriental Bioengineering Inc
Buy, Hold or Sell?

Let's analyze American Oriental Bioengineering Inc together

I guess you are interested in American Oriental Bioengineering Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of American Oriental Bioengineering Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about American Oriental Bioengineering Inc

I send you an email if I find something interesting about American Oriental Bioengineering Inc.

1. Quick Overview

1.1. Quick analysis of American Oriental Bioengineering Inc (30 sec.)










1.2. What can you expect buying and holding a share of American Oriental Bioengineering Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$4,285.04
Expected worth in 1 year
$1,009.97
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
$-3,275.06
Return On Investment
-655,012,413.7%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.0005 - $0.0005
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of American Oriental Bioengineering Inc (5 min.)




Live pricePrice per Share (EOD)
$0.00
Intrinsic Value Per Share
$-17,627.10 - $-5,193.16
Total Value Per Share
$-13,342.07 - $-908.13

2.2. Growth of American Oriental Bioengineering Inc (5 min.)




Is American Oriental Bioengineering Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$327.5m$381.1m-$53.5m-16.4%

How much money is American Oriental Bioengineering Inc making?

Current yearPrevious yearGrowGrow %
Making money-$59.7m-$68.4m$8.7m14.7%
Net Profit Margin-41.2%-32.2%--

How much money comes from the company's main activities?

2.3. Financial Health of American Oriental Bioengineering Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of American Oriental Bioengineering Inc?

Welcome investor! American Oriental Bioengineering Inc's management wants to use your money to grow the business. In return you get a share of American Oriental Bioengineering Inc.

First you should know what it really means to hold a share of American Oriental Bioengineering Inc. And how you can make/lose money.

Speculation

The Price per Share of American Oriental Bioengineering Inc is $0.0005. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of American Oriental Bioengineering Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in American Oriental Bioengineering Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $4,285.04. Based on the TTM, the Book Value Change Per Share is $-818.77 per quarter. Based on the YOY, the Book Value Change Per Share is $-597.98 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of American Oriental Bioengineering Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-781.08-156,216,641.2%-781.08-156,216,641.2%-903.16-180,632,355.9%-91.94-18,388,843.1%88.6917,737,940.0%
Usd Book Value Change Per Share-818.77-163,753,103.4%-818.77-163,753,103.4%-597.98-119,595,956.2%-0.86-172,096.8%416.9583,389,539.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-818.77-163,753,103.4%-818.77-163,753,103.4%-597.98-119,595,956.2%-0.86-172,096.8%416.9583,389,539.0%
Usd Price Per Share0.34-0.34-0.56-2.95-4.71-
Price to Earnings Ratio0.00-0.00-0.00-0.01-0.02-
Price-to-Total Gains Ratio0.00-0.00-0.00--0.01-0.00-
Price to Book Ratio0.00-0.00-0.00-0.00-0.00-
Price-to-Total Gains Ratio0.00-0.00-0.00--0.01-0.00-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0005
Number of shares2000000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-818.77-0.86
Usd Total Gains Per Share-818.77-0.86
Gains per Quarter (2000000 shares)-1,637,531,034.36-1,720,968.25
Gains per Year (2000000 shares)-6,550,124,137.43-6,883,872.98
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-6550124137-65501241470-6883873-6883883
20-13100248275-131002482840-13767746-13767756
30-19650372412-196503724210-20651619-20651629
40-26200496550-262004965580-27535492-27535502
50-32750620687-327506206950-34419365-34419375
60-39300744825-393007448320-41303238-41303248
70-45850868962-458508689690-48187111-48187121
80-52400993099-524009931060-55070984-55070994
90-58951117237-589511172430-61954857-61954867
100-65501241374-655012413800-68838730-68838740

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%8.02.00.080.0%10.03.00.076.9%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%7.03.00.070.0%9.04.00.069.2%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.013.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%7.03.00.070.0%9.04.00.069.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of American Oriental Bioengineering Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---818.766-818.7660%-597.980-27%-0.860-100%416.948-296%
Book Value Per Share--4285.0364285.0360%5103.801-16%4747.460-10%3211.526+33%
Current Ratio--0.8990.8990%1.226-27%2.694-67%4.198-79%
Debt To Asset Ratio--0.2660.2660%0.325-18%0.308-14%0.227+17%
Debt To Equity Ratio--0.3620.3620%0.482-25%0.448-19%0.312+16%
Dividend Per Share----0%-0%-0%-0%
Eps---781.083-781.0830%-903.162+16%-91.944-88%88.690-981%
Free Cash Flow Per Share---949.599-949.5990%-266.711-72%-423.782-55%-98.901-90%
Free Cash Flow To Equity Per Share---1152.162-1152.1620%-323.777-72%-295.957-74%197.120-684%
Gross Profit Margin--1.4861.4860%1.218+22%0.170+775%0.345+331%
Intrinsic Value_10Y_max---5193.163--------
Intrinsic Value_10Y_min---17627.102--------
Intrinsic Value_1Y_max---190.198--------
Intrinsic Value_1Y_min---770.084--------
Intrinsic Value_3Y_max---823.115--------
Intrinsic Value_3Y_min---3190.396--------
Intrinsic Value_5Y_max---1759.422--------
Intrinsic Value_5Y_min---6552.880--------
Market Cap36.496-71122%25992.66025992.6600%41881.666-38%244197.207-89%358297.480-93%
Net Profit Margin---0.412-0.4120%-0.322-22%-0.072-83%0.088-566%
Operating Margin---0.337-0.3370%-0.288-14%0.001-26444%0.159-312%
Operating Ratio--1.3791.3790%1.011+36%0.961+44%0.822+68%
Pb Ratio0.000-67900%0.0000.0000%0.000-28%0.001-88%0.003-98%
Pe Ratio0.000+100%0.0000.0000%-0.001+43%0.007-106%0.018-102%
Price Per Share0.001-67900%0.3400.3400%0.561-39%2.948-88%4.710-93%
Price To Free Cash Flow Ratio0.000+100%0.0000.0000%-0.002+487%0.021-102%0.033-101%
Price To Total Gains Ratio0.000+100%0.0000.0000%-0.001+126%-0.014+3154%-0.001+132%
Quick Ratio--0.6010.6010%0.952-37%2.225-73%3.464-83%
Return On Assets---0.134-0.1340%-0.121-9%-0.013-90%0.074-280%
Return On Equity---0.182-0.1820%-0.179-2%-0.016-91%0.088-308%
Total Gains Per Share---818.766-818.7660%-597.980-27%-0.860-100%416.948-296%
Usd Book Value--327586706.000327586706.0000%381162094.000-14%376113105.400-13%249208130.100+31%
Usd Book Value Change Per Share---818.766-818.7660%-597.980-27%-0.860-100%416.948-296%
Usd Book Value Per Share--4285.0364285.0360%5103.801-16%4747.460-10%3211.526+33%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---781.083-781.0830%-903.162+16%-91.944-88%88.690-981%
Usd Free Cash Flow---72595858.000-72595858.0000%-19918481.000-73%-33035260.800-54%-8270415.000-89%
Usd Free Cash Flow Per Share---949.599-949.5990%-266.711-72%-423.782-55%-98.901-90%
Usd Free Cash Flow To Equity Per Share---1152.162-1152.1620%-323.777-72%-295.957-74%197.120-684%
Usd Market Cap36.496-71122%25992.66025992.6600%41881.666-38%244197.207-89%358297.480-93%
Usd Price Per Share0.001-67900%0.3400.3400%0.561-39%2.948-88%4.710-93%
Usd Profit---59725397.000-59725397.0000%-68491348.000+15%-4529671.200-92%7564328.000-890%
Usd Revenue--145099627.000145099627.0000%212690388.000-32%244905587.600-41%160275460.600-9%
Usd Total Gains Per Share---818.766-818.7660%-597.980-27%-0.860-100%416.948-296%
 EOD+3 -5MRQTTM+0 -0YOY+9 -255Y+8 -2610Y+9 -25

3.3 Fundamental Score

Let's check the fundamental score of American Oriental Bioengineering Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-150.000
Price to Book Ratio (EOD)Between0-10.000
Net Profit Margin (MRQ)Greater than0-0.412
Operating Margin (MRQ)Greater than0-0.337
Quick Ratio (MRQ)Greater than10.601
Current Ratio (MRQ)Greater than10.899
Debt to Asset Ratio (MRQ)Less than10.266
Debt to Equity Ratio (MRQ)Less than10.362
Return on Equity (MRQ)Greater than0.15-0.182
Return on Assets (MRQ)Greater than0.05-0.134
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of American Oriental Bioengineering Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.000
Ma 20Greater thanMa 500.001
Ma 50Greater thanMa 1000.001
Ma 100Greater thanMa 2000.001
OpenGreater thanClose0.001
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About American Oriental Bioengineering Inc

American Oriental Bioengineering, Inc. engages in the development, manufacture, and commercialization of various pharmaceutical and healthcare products. The company primarily provides prescription pharmaceutical products, including Shuanghuanglian Lyophilized Injection Powder under the SHL brand for the treatment of flu symptoms, such as high fever, cough, and sore throat, as well as upper respiratory infections, mild pneumonia, bronchitis, and tonsillitis; and Cease Enuresis Soft Gel under the CE Gel brand to alleviate bedwetting. It also offers over-the-counter pharmaceutical products comprising Cease Enuresis Patch for the treatment of bedwetting and incontinence; Jinji Capsule for the treatment of endometritis, annexitis, and pelvic inflammations; Jinji Yimucao for the treatment of premenstrual syndrome (PMS) and other PMS and menopause-related symptoms; and Boke Nasal Spray for the treatment of sinus congestion from common cold, stuffy nose, chronic rhinitis, allergic rhinitis, and nasosinusitis. In addition, the company provides various nutraceutical products, such as soybean peptide based drinks, tablets, powder, and instant coffee. Further, it is involved in the wholesale and retail of pharmaceutical and nutraceutical products. The company sells its products directly and through distributors to hospitals, clinics, pharmacies, supermarkets, fitness centers, specialty nutraceutical stores, and other retail outlets in the People's Republic of China. American Oriental Bioengineering, Inc. is headquartered in Beijing, China.

Fundamental data was last updated by Penke on 2024-11-22 11:31:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit American Oriental Bioengineering Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare American Oriental Bioengineering Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -41.2% means that $-0.41 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of American Oriental Bioengineering Inc:

  • The MRQ is -41.2%. The company is making a huge loss. -2
  • The TTM is -41.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-41.2%TTM-41.2%0.0%
TTM-41.2%YOY-32.2%-9.0%
TTM-41.2%5Y-7.2%-34.0%
5Y-7.2%10Y8.8%-16.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-41.2%-110.9%+69.7%
TTM-41.2%-214.4%+173.2%
YOY-32.2%-210.0%+177.8%
5Y-7.2%-339.1%+331.9%
10Y8.8%-464.5%+473.3%
4.3.1.2. Return on Assets

Shows how efficient American Oriental Bioengineering Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare American Oriental Bioengineering Inc to the Biotechnology industry mean.
  • -13.4% Return on Assets means that American Oriental Bioengineering Inc generated $-0.13 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of American Oriental Bioengineering Inc:

  • The MRQ is -13.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -13.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-13.4%TTM-13.4%0.0%
TTM-13.4%YOY-12.1%-1.3%
TTM-13.4%5Y-1.3%-12.1%
5Y-1.3%10Y7.4%-8.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.4%-11.2%-2.2%
TTM-13.4%-11.7%-1.7%
YOY-12.1%-11.3%-0.8%
5Y-1.3%-12.7%+11.4%
10Y7.4%-14.2%+21.6%
4.3.1.3. Return on Equity

Shows how efficient American Oriental Bioengineering Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare American Oriental Bioengineering Inc to the Biotechnology industry mean.
  • -18.2% Return on Equity means American Oriental Bioengineering Inc generated $-0.18 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of American Oriental Bioengineering Inc:

  • The MRQ is -18.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -18.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-18.2%TTM-18.2%0.0%
TTM-18.2%YOY-17.9%-0.3%
TTM-18.2%5Y-1.6%-16.6%
5Y-1.6%10Y8.8%-10.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-18.2%-14.2%-4.0%
TTM-18.2%-15.8%-2.4%
YOY-17.9%-14.2%-3.7%
5Y-1.6%-18.5%+16.9%
10Y8.8%-19.5%+28.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of American Oriental Bioengineering Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient American Oriental Bioengineering Inc is operating .

  • Measures how much profit American Oriental Bioengineering Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare American Oriental Bioengineering Inc to the Biotechnology industry mean.
  • An Operating Margin of -33.7% means the company generated $-0.34  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of American Oriental Bioengineering Inc:

  • The MRQ is -33.7%. The company is operating very inefficient. -2
  • The TTM is -33.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-33.7%TTM-33.7%0.0%
TTM-33.7%YOY-28.8%-4.9%
TTM-33.7%5Y0.1%-33.8%
5Y0.1%10Y15.9%-15.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-33.7%-222.9%+189.2%
TTM-33.7%-306.4%+272.7%
YOY-28.8%-221.9%+193.1%
5Y0.1%-387.1%+387.2%
10Y15.9%-498.7%+514.6%
4.3.2.2. Operating Ratio

Measures how efficient American Oriental Bioengineering Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.38 means that the operating costs are $1.38 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of American Oriental Bioengineering Inc:

  • The MRQ is 1.379. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.379. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.379TTM1.3790.000
TTM1.379YOY1.011+0.368
TTM1.3795Y0.961+0.418
5Y0.96110Y0.822+0.138
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3792.465-1.086
TTM1.3793.244-1.865
YOY1.0113.298-2.287
5Y0.9614.788-3.827
10Y0.8226.517-5.695
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of American Oriental Bioengineering Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if American Oriental Bioengineering Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.90 means the company has $0.90 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of American Oriental Bioengineering Inc:

  • The MRQ is 0.899. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.899. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.899TTM0.8990.000
TTM0.899YOY1.226-0.327
TTM0.8995Y2.694-1.795
5Y2.69410Y4.198-1.505
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8993.610-2.711
TTM0.8993.877-2.978
YOY1.2264.633-3.407
5Y2.6945.938-3.244
10Y4.1986.265-2.067
4.4.3.2. Quick Ratio

Measures if American Oriental Bioengineering Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare American Oriental Bioengineering Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.60 means the company can pay off $0.60 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of American Oriental Bioengineering Inc:

  • The MRQ is 0.601. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.601. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.601TTM0.6010.000
TTM0.601YOY0.952-0.351
TTM0.6015Y2.225-1.624
5Y2.22510Y3.464-1.239
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6013.048-2.447
TTM0.6013.426-2.825
YOY0.9524.449-3.497
5Y2.2255.927-3.702
10Y3.4646.424-2.960
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of American Oriental Bioengineering Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of American Oriental Bioengineering Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare American Oriental Bioengineering Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.27 means that American Oriental Bioengineering Inc assets are financed with 26.6% credit (debt) and the remaining percentage (100% - 26.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of American Oriental Bioengineering Inc:

  • The MRQ is 0.266. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.266. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.266TTM0.2660.000
TTM0.266YOY0.325-0.059
TTM0.2665Y0.308-0.042
5Y0.30810Y0.227+0.081
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2660.353-0.087
TTM0.2660.346-0.080
YOY0.3250.311+0.014
5Y0.3080.366-0.058
10Y0.2270.383-0.156
4.5.4.2. Debt to Equity Ratio

Measures if American Oriental Bioengineering Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare American Oriental Bioengineering Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 36.2% means that company has $0.36 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of American Oriental Bioengineering Inc:

  • The MRQ is 0.362. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.362. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.362TTM0.3620.000
TTM0.362YOY0.482-0.119
TTM0.3625Y0.448-0.086
5Y0.44810Y0.312+0.136
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3620.395-0.033
TTM0.3620.435-0.073
YOY0.4820.380+0.102
5Y0.4480.451-0.003
10Y0.3120.493-0.181
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings American Oriental Bioengineering Inc generates.

  • Above 15 is considered overpriced but always compare American Oriental Bioengineering Inc to the Biotechnology industry mean.
  • A PE ratio of 0.00 means the investor is paying $0.00 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of American Oriental Bioengineering Inc:

  • The EOD is 0.000. Based on the earnings, the company is expensive. -2
  • The MRQ is 0.000. Based on the earnings, the company is expensive. -2
  • The TTM is 0.000. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD0.000MRQ0.000+0.000
MRQ0.000TTM0.0000.000
TTM0.000YOY-0.001+0.000
TTM0.0005Y0.007-0.007
5Y0.00710Y0.018-0.011
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.000-2.251+2.251
MRQ0.000-2.398+2.398
TTM0.000-3.147+3.147
YOY-0.001-3.237+3.236
5Y0.007-6.021+6.028
10Y0.018-6.731+6.749
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of American Oriental Bioengineering Inc:

  • The EOD is 0.000. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 0.000. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 0.000. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD0.000MRQ0.000+0.000
MRQ0.000TTM0.0000.000
TTM0.000YOY-0.002+0.002
TTM0.0005Y0.021-0.021
5Y0.02110Y0.033-0.012
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.000-2.954+2.954
MRQ0.000-3.234+3.234
TTM0.000-3.730+3.730
YOY-0.002-4.523+4.521
5Y0.021-8.196+8.217
10Y0.033-9.244+9.277
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of American Oriental Bioengineering Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.00 means the investor is paying $0.00 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of American Oriental Bioengineering Inc:

  • The EOD is 0.000. Based on the equity, the company is cheap. +2
  • The MRQ is 0.000. Based on the equity, the company is cheap. +2
  • The TTM is 0.000. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.000MRQ0.0000.000
MRQ0.000TTM0.0000.000
TTM0.000YOY0.0000.000
TTM0.0005Y0.001-0.001
5Y0.00110Y0.003-0.003
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.0001.931-1.931
MRQ0.0002.039-2.039
TTM0.0002.343-2.343
YOY0.0002.431-2.431
5Y0.0013.698-3.697
10Y0.0034.362-4.359
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2008-12-312009-12-312010-12-312011-12-312012-12-31
Net Working Capital  86,41644,528130,94331,232162,175-126,04436,131-46,894-10,763



6.2. Latest Balance Sheet

Balance Sheet of 2012-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets446,309
Total Liabilities118,722
Total Stockholder Equity327,587
 As reported
Total Liabilities 118,722
Total Stockholder Equity+ 327,587
Total Assets = 446,309

Assets

Total Assets446,309
Total Current Assets95,448
Long-term Assets350,860
Total Current Assets
Cash And Cash Equivalents 7,097
Short-term Investments 6,514
Net Receivables 50,226
Inventory 20,571
Other Current Assets 17,554
Total Current Assets  (as reported)95,448
Total Current Assets  (calculated)101,962
+/- 6,514
Long-term Assets
Property Plant Equipment 171,381
Long Term Investments 3,337
Intangible Assets 175,875
Long-term Assets Other 267
Long-term Assets  (as reported)350,860
Long-term Assets  (calculated)350,860
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities106,212
Long-term Liabilities12,511
Total Stockholder Equity327,587
Total Current Liabilities
Short-term Debt 56,034
Short Long Term Debt 49,226
Accounts payable 11,005
Other Current Liabilities 24,483
Total Current Liabilities  (as reported)106,212
Total Current Liabilities  (calculated)140,748
+/- 34,536
Long-term Liabilities
Long term Debt 554
Other Liabilities 11,956
Deferred Long Term Liability 213
Long-term Liabilities  (as reported)12,511
Long-term Liabilities  (calculated)12,723
+/- 212
Total Stockholder Equity
Common Stock524
Retained Earnings 78,098
Accumulated Other Comprehensive Income 71,790
Treasury Stock-800
Other Stockholders Equity 178,075
Total Stockholder Equity (as reported)327,587
Total Stockholder Equity (calculated)327,687
+/- 100
Other
Cash and Short Term Investments 7,097
Common Stock Shares Outstanding 76
Current Deferred Revenue1,423
Liabilities and Stockholders Equity 446,309
Net Debt 60,546
Net Tangible Assets 169,154
Net Working Capital -10,763
Preferred Stock Total Equity 1
Short Long Term Debt Total 67,643



6.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
> Total Assets 
63
396
10,848
21,673
42,837
99,422
185,274
353,715
524,055
576,482
611,545
564,981
446,309
446,309564,981611,545576,482524,055353,715185,27499,42242,83721,67310,84839663
   > Total Current Assets 
37
396
5,864
13,775
24,358
75,376
115,587
206,872
132,452
177,917
206,252
195,911
95,448
95,448195,911206,252177,917132,452206,872115,58775,37624,35813,7755,86439637
       Cash And Cash Equivalents 
10
0
2,817
5,367
11,404
57,532
87,784
166,410
70,637
91,126
94,569
52,628
7,097
7,09752,62894,56991,12670,637166,41087,78457,53211,4045,3672,817010
       Short-term Investments 
0
0
0
0
0
0
0
0
0
3,298
537
264
6,514
6,5142645373,298000000000
       Net Receivables 
3
0
1,761
3,257
4,893
8,271
14,417
18,754
37,690
57,504
80,599
99,199
50,226
50,22699,19980,59957,50437,69018,75414,4178,2714,8933,2571,76103
       Inventory 
23
0
496
2,547
5,673
4,917
10,684
12,265
13,042
10,016
12,666
18,890
20,571
20,57118,89012,66610,01613,04212,26510,6844,9175,6732,547496023
   > Long-term Assets 
26
0
4,984
7,897
18,479
24,047
69,687
146,843
391,603
398,564
405,293
369,070
350,860
350,860369,070405,293398,564391,603146,84369,68724,04718,4797,8974,984026
       Property Plant Equipment 
26
0
4,261
7,265
9,905
15,042
32,521
49,252
123,540
124,444
132,064
170,534
171,381
171,381170,534132,064124,444123,54049,25232,52115,0429,9057,2654,261026
       Goodwill 
0
0
0
0
0
0
1,933
22,567
28,543
33,164
33,164
0
0
0033,16433,16428,54322,5671,933000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
57,242
19,179
5,934
3,337
3,3375,93419,17957,242000000000
       Intangible Assets 
0
0
0
1,434
8,414
8,390
33,321
73,282
172,679
172,300
170,322
168,657
175,875
175,875168,657170,322172,300172,67973,28233,3218,3908,4141,434000
       Long-term Assets Other 
1
0
723
633
0
0
114
243
65,526
11,197
10,527
23,682
267
26723,68210,52711,19765,5262431140063372301
> Total Liabilities 
578
1
2,413
3,162
9,696
8,818
29,097
40,632
178,195
181,426
180,644
183,819
118,722
118,722183,819180,644181,426178,19540,63229,0978,8189,6963,1622,4131578
   > Total Current Liabilities 
332
1
2,413
3,137
9,554
8,562
23,335
26,461
46,036
46,974
44,077
159,779
106,212
106,212159,77944,07746,97446,03626,46123,3358,5629,5543,1372,4131332
       Short-term Debt 
0
0
1,446
1,453
5,073
3,717
9,832
8,736
10,462
13,837
7,019
115,822
56,034
56,034115,8227,01913,83710,4628,7369,8323,7175,0731,4531,44600
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
60
61
108,563
49,226
49,226108,5636160000000000
       Accounts payable 
0
1
582
1,254
755
1,231
2,872
3,436
12,288
7,497
11,254
22,086
11,005
11,00522,08611,2547,49712,2883,4362,8721,2317551,25458210
       Other Current Liabilities 
0
0
385
430
3,726
3,614
10,631
14,179
22,441
24,546
24,567
19,687
24,483
24,48319,68724,56724,54622,44114,17910,6313,6143,72643038500
   > Long-term Liabilities 
246
0
0
25
142
256
5,762
14,171
132,158
134,452
136,568
24,040
12,511
12,51124,040136,568134,452132,15814,1715,7622561422500246
       Other Liabilities 
0
0
0
0
0
23
9
0
0
18,708
21,893
14,572
11,956
11,95614,57221,89318,7080092300000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
3,288
2,359
1,348
213
2131,3482,3593,288000000000
> Total Stockholder Equity
-515
395
8,435
18,510
33,140
90,605
156,177
313,083
345,208
394,523
430,396
381,698
327,587
327,587381,698430,396394,523345,208313,083156,17790,60533,14018,5108,435395-515
   Common Stock
32
10
11
33
40
57
64
78
78
78
79
370
524
5243707978787864574033111032
   Retained Earnings 
-1,836
-1,589
3,826
8,428
16,199
29,626
58,827
102,118
149,924
191,174
207,515
137,811
78,098
78,098137,811207,515191,174149,924102,11858,82729,62616,1998,4283,826-1,589-1,836
   Capital Surplus 0000000000000
   Treasury Stock-800-80000000000000
   Other Stockholders Equity 
1,289
1,974
4,597
10,049
16,900
59,491
92,308
193,008
195,742
170,219
203,673
176,084
178,075
178,075176,084203,673170,219195,742193,00892,30859,49116,90010,0494,5971,9741,289



6.4. Balance Sheets

Currency in USD. All numbers in thousands.




6.5. Cash Flows

Currency in USD. All numbers in thousands.




6.6. Income Statements

Currency in USD. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2012-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue145,100
Cost of Revenue-100,742
Gross Profit44,35844,358
 
Operating Income (+$)
Gross Profit44,358
Operating Expense-99,330
Operating Income-54,972-54,972
 
Operating Expense (+$)
Research Development6,246
Selling General Administrative49,726
Selling And Marketing Expenses29,025
Operating Expense99,33084,997
 
Net Interest Income (+$)
Interest Income0
Interest Expense-5,835
Other Finance Cost-5,835
Net Interest Income0
 
Pretax Income (+$)
Operating Income-54,972
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-57,501-52,444
EBIT - interestExpense = -54,688
-57,501
-53,891
Interest Expense5,835
Earnings Before Interest and Taxes (EBIT)-48,853-51,666
Earnings Before Interest and Taxes (EBITDA)-39,637
 
After tax Income (+$)
Income Before Tax-57,501
Tax Provision-0
Net Income From Continuing Ops-59,725-57,501
Net Income-59,725
Net Income Applicable To Common Shares-59,713
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring38,446
Other Operating Expenses200,072
Total Other Income/Expenses Net-2,5290
 

Technical Analysis of American Oriental Bioengineering Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of American Oriental Bioengineering Inc. The general trend of American Oriental Bioengineering Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine American Oriental Bioengineering Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of American Oriental Bioengineering Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.0005 < 0.0005 < 0.0005.

The bearish price targets are: 0.0005 > 0.0005 > 0.0005.

Tweet this
American Oriental Bioengineering Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of American Oriental Bioengineering Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

American Oriental Bioengineering Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of American Oriental Bioengineering Inc. The current macd is 0.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the American Oriental Bioengineering Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for American Oriental Bioengineering Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the American Oriental Bioengineering Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
American Oriental Bioengineering Inc Daily Moving Average Convergence/Divergence (MACD) ChartAmerican Oriental Bioengineering Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of American Oriental Bioengineering Inc. The current adx is 100.00.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
American Oriental Bioengineering Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of American Oriental Bioengineering Inc. The current sar is 0.0005.

American Oriental Bioengineering Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of American Oriental Bioengineering Inc. The current rsi is 0. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
American Oriental Bioengineering Inc Daily Relative Strength Index (RSI) ChartAmerican Oriental Bioengineering Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of American Oriental Bioengineering Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the American Oriental Bioengineering Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
American Oriental Bioengineering Inc Daily Stochastic Oscillator ChartAmerican Oriental Bioengineering Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of American Oriental Bioengineering Inc. The current cci is -66.66666667.

American Oriental Bioengineering Inc Daily Commodity Channel Index (CCI) ChartAmerican Oriental Bioengineering Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of American Oriental Bioengineering Inc. The current cmo is 0.

American Oriental Bioengineering Inc Daily Chande Momentum Oscillator (CMO) ChartAmerican Oriental Bioengineering Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of American Oriental Bioengineering Inc. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
American Oriental Bioengineering Inc Daily Williams %R ChartAmerican Oriental Bioengineering Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of American Oriental Bioengineering Inc.

American Oriental Bioengineering Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of American Oriental Bioengineering Inc. The current atr is 0.

American Oriental Bioengineering Inc Daily Average True Range (ATR) ChartAmerican Oriental Bioengineering Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of American Oriental Bioengineering Inc. The current obv is 200.00.

American Oriental Bioengineering Inc Daily On-Balance Volume (OBV) ChartAmerican Oriental Bioengineering Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of American Oriental Bioengineering Inc. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
American Oriental Bioengineering Inc Daily Money Flow Index (MFI) ChartAmerican Oriental Bioengineering Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for American Oriental Bioengineering Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal

6.3. Candlestick Patterns

American Oriental Bioengineering Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of American Oriental Bioengineering Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.000
Ma 20Greater thanMa 500.001
Ma 50Greater thanMa 1000.001
Ma 100Greater thanMa 2000.001
OpenGreater thanClose0.001
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of American Oriental Bioengineering Inc with someone you think should read this too:
  • Are you bullish or bearish on American Oriental Bioengineering Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about American Oriental Bioengineering Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about American Oriental Bioengineering Inc

I send you an email if I find something interesting about American Oriental Bioengineering Inc.


Comments

How you think about this?

Leave a comment

Stay informed about American Oriental Bioengineering Inc.

Receive notifications about American Oriental Bioengineering Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.